Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Lung Cancer Treatment Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Lung Cancer Treatment Drugsmarket, defines the market attractiveness level of Lung Cancer Treatment Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Lung Cancer Treatment Drugs industry, describes the types of Lung Cancer Treatment Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Lung Cancer Treatment Drugs market and the development prospects and opportunities of Lung Cancer Treatment Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Lung Cancer Treatment Drugs market in Chapter 13.
By Player:
AstraZeneca
Roche
Eli Lilly and Company
GlaxoSmithKline
Sanofi-Aventis
Pfizer
By Type:
Chemotherapy
Targeted Therapies
Pipeline Drugs
By End-User:
Hospitals
Research Institutes
Diagnostic Centers
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Lung Cancer Treatment Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Lung Cancer Treatment Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Lung Cancer Treatment Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Lung Cancer Treatment Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Lung Cancer Treatment Drugs Market Analysis and Outlook to 2022
-
7.1 Global Lung Cancer Treatment Drugs Consumption (2017-2022)
-
7.2 United States Lung Cancer Treatment Drugs Consumption (2017-2022)
-
7.3 Europe Lung Cancer Treatment Drugs Consumption (2017-2022)
-
7.4 China Lung Cancer Treatment Drugs Consumption (2017-2022)
-
7.5 Japan Lung Cancer Treatment Drugs Consumption (2017-2022)
-
7.6 India Lung Cancer Treatment Drugs Consumption (2017-2022)
-
7.7 South Korea Lung Cancer Treatment Drugs Consumption (2017-2022)
8 Region and Country-wise Lung Cancer Treatment Drugs Market Analysis and Outlook to 2028
-
8.1 Global Lung Cancer Treatment Drugs Consumption Forecast (2022-2028)
-
8.2 United States Lung Cancer Treatment Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Lung Cancer Treatment Drugs Consumption Forecast (2022-2028)
-
8.4 China Lung Cancer Treatment Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Lung Cancer Treatment Drugs Consumption Forecast (2022-2028)
-
8.6 India Lung Cancer Treatment Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Lung Cancer Treatment Drugs Consumption Forecast (2022-2028)
9 Global Lung Cancer Treatment Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Lung Cancer Treatment Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Targeted Therapies Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Pipeline Drugs Consumption and Growth Rate (2017-2022)
-
9.2 Global Lung Cancer Treatment Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Research Institutes Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Diagnostic Centers Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Lung Cancer Treatment Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Lung Cancer Treatment Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Pipeline Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Lung Cancer Treatment Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Lung Cancer Treatment Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Lung Cancer Treatment Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Lung Cancer Treatment Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Lung Cancer Treatment Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Lung Cancer Treatment Drugs Market Competitive Analysis
-
14.1 AstraZeneca
-
14.1.1 AstraZeneca Company Details
-
14.1.2 AstraZeneca Lung Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AstraZeneca Lung Cancer Treatment Drugs Product and Service
-
14.2 Roche
-
14.2.1 Roche Company Details
-
14.2.2 Roche Lung Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Roche Lung Cancer Treatment Drugs Product and Service
-
14.3 Eli Lilly and Company
-
14.3.1 Eli Lilly and Company Company Details
-
14.3.2 Eli Lilly and Company Lung Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Eli Lilly and Company Lung Cancer Treatment Drugs Product and Service
-
14.4 GlaxoSmithKline
-
14.4.1 GlaxoSmithKline Company Details
-
14.4.2 GlaxoSmithKline Lung Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlaxoSmithKline Lung Cancer Treatment Drugs Product and Service
-
14.5 Sanofi-Aventis
-
14.5.1 Sanofi-Aventis Company Details
-
14.5.2 Sanofi-Aventis Lung Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Sanofi-Aventis Lung Cancer Treatment Drugs Product and Service
-
14.6 Pfizer
-
14.6.1 Pfizer Company Details
-
14.6.2 Pfizer Lung Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pfizer Lung Cancer Treatment Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Lung Cancer Treatment Drugs
-
Figure Lung Cancer Treatment Drugs Picture
-
Table Global Lung Cancer Treatment Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Lung Cancer Treatment Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Lung Cancer Treatment Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Lung Cancer Treatment Drugs Consumption by Country (2017-2022)
-
Figure United States Lung Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Lung Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Lung Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Lung Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Lung Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Lung Cancer Treatment Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Cancer Treatment Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Lung Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Lung Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Lung Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Lung Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Lung Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Lung Cancer Treatment Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Targeted Therapies Consumption and Growth Rate (2017-2022)
-
Figure Global Pipeline Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Research Institutes Consumption and Growth Rate (2017-2022)
-
Figure Global Diagnostic Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Targeted Therapies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pipeline Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Institutes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diagnostic Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Lung Cancer Treatment Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Lung Cancer Treatment Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Lung Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Lung Cancer Treatment Drugs Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Lung Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Lung Cancer Treatment Drugs Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Lung Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Lung Cancer Treatment Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Lung Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Lung Cancer Treatment Drugs Product and Service
-
Table Sanofi-Aventis (Foundation Year, Company Profile and etc.)
-
Table Sanofi-Aventis Lung Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi-Aventis Lung Cancer Treatment Drugs Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Lung Cancer Treatment Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Lung Cancer Treatment Drugs Product and Service
-
